Design Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-66.86	-63.31	-35.53	-8.28	-2.05
Depreciation & Amortization	0.57	0.47	0.15	0.01	0
Share-Based Compensation	13.09	10.93	4.69	0.45	0
Other Operating Activities	-5.36	0.6	1.32	-0.84	1.91
Operating Cash Flow	-58.56	-51.32	-29.38	-8.67	-0.14
Capital Expenditures	-0.26	-0.88	-1.54	-0.08	0
Change in Investments	52.79	-220.11	-52.11	-33.49	0
Investing Cash Flow	52.54	-220.99	-53.64	-33.56	0
Share Issuance / Repurchase	0.72	0.66	254.5	0	0
Debt Issued / Paid	0	0	0	-0.2	0.2
Other Financing Activities	-	-0.43	124.71	44.73	-
Financing Cash Flow	0.72	0.24	379.21	44.53	0.2
Net Cash Flow	-5.3	-272.07	296.19	2.3	0.06
Free Cash Flow	-58.82	-52.2	-30.92	-8.75	-0.14
Free Cash Flow Margin	-	-	-	-3869.47%	-16.67%
Free Cash Flow Per Share	-1.05	-0.94	-0.67	-0.55	-0.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).